Lanean...
Activation of Cannabinoid CB(2) receptors Reduces Hyperalgesia in an Experimental Autoimmune Encephalomyelitis Mouse Model of Multiple Sclerosis
Clinical trials investigating the analgesic efficacy of cannabinoids in multiple sclerosis have yielded mixed results, possibly due to psychotropic side effects mediated by cannabinoid CB(1) receptors. We hypothesized that a CB(2)-specific agonist (JWH-133) would decrease hyperalgesia in an experime...
Gorde:
| Argitaratua izan da: | Neurosci Lett |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4464808/ https://ncbi.nlm.nih.gov/pubmed/25849525 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neulet.2015.04.002 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|